Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03725241 · ClinicalTrials.gov registry record · NA

Effects of Glutathione on Immunity in Individuals Training for a Marathon

A NA study of Healthy, sponsored by University of North Texas, Denton, TX.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT03725241 is a NA study of Healthy that has completed, run by University of North Texas, Denton, TX. The registered enrollment target is 84 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03725241, a NA study of Healthy, has completed, sponsored by University of North Texas, Denton, TX.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the effects of glutathione supplement on the immune cell response and symptomatology of upper respiratory health, and antioxidant capacity in healthy people in exercise-induced model.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo Supplement
  • DIETARY_SUPPLEMENT Glutathione Supplement

Study Locations (1)

Texas

  • University of North Texas - Denton

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2018-10-29
Est. Completion 2020-05-01
Phase NA

What the Registry Record Tells You About NCT03725241

The ClinicalTrials.gov registry entry for NCT03725241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower). The listed sponsor is University of North Texas, Denton, TX, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo Supplement is the first listed.

NCT03725241 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03725241 about?

NCT03725241 is a clinical study titled "Effects of Glutathione on Immunity in Individuals Training for a Marathon". The aim of this study is to determine the effects of glutathione supplement on the immune cell response and symptomatology of upper respiratory health, and antioxidant capacity in healthy people in exercise-induced model.

What is the current status of trial NCT03725241?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2018-10-29. Estimated completion is 2020-05-01.

What conditions does trial NCT03725241 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03725241?

The interventions under investigation include: Placebo Supplement (DIETARY_SUPPLEMENT), Glutathione Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03725241?

This trial is sponsored by University of North Texas, Denton, TX, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03725241 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.